ATGENOMIX, founded in 2017, is a pioneering company in the converging fields of biotechnology, health care, and information technology. Based in Taiwan, the company operates with the slogan, "Data and AI-driven Precision Medicine."
Their standout product is a cloud-based biomedical informatics platform designed to unify and operationalize biomedical data leveraging both data analytics and machine learning. This platform is particularly noteworthy for adhering to GA4GH standards, enabling advanced workflows in clinical laboratories.
ATGENOMIX is supported by strategic partnerships with tech giants, being a Microsoft Azure cloud partner in gold data and cloud platform competencies and a Google Health trusted partner in genomics research. Their last significant investment, a Series A round on 01 February 2020, drew backing from notable investors like TransLink Capital, Darwin Venture Management, and Bill Chang. This financial backing emphasizes strong investor confidence in ATGENOMIX's mission to transform healthcare through precision medicine.